Acasti Pharma Inc (ACST)
2.88
-0.08
(-2.70%)
USD |
NASDAQ |
May 06, 12:23
Acasti Pharma 1 Year Total Returns (Daily): 10.17% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 10.17% |
| May 02, 2024 | 16.71% |
| May 01, 2024 | 4.03% |
| April 30, 2024 | 2.06% |
| April 29, 2024 | -1.62% |
| April 26, 2024 | 7.31% |
| April 25, 2024 | 2.73% |
| April 24, 2024 | 0.82% |
| April 23, 2024 | 3.23% |
| April 22, 2024 | 2.15% |
| April 19, 2024 | 1.66% |
| April 18, 2024 | 6.82% |
| April 17, 2024 | 11.36% |
| April 16, 2024 | 18.84% |
| April 15, 2024 | 19.20% |
| April 12, 2024 | 23.10% |
| April 11, 2024 | 20.57% |
| April 10, 2024 | 23.32% |
| April 09, 2024 | 29.02% |
| April 08, 2024 | 29.02% |
| April 05, 2024 | 31.60% |
| April 04, 2024 | 25.79% |
| April 03, 2024 | 22.46% |
| April 02, 2024 | 24.30% |
| April 01, 2024 | 25.03% |
| Date | Value |
|---|---|
| March 28, 2024 | 32.41% |
| March 27, 2024 | 31.45% |
| March 26, 2024 | 31.78% |
| March 25, 2024 | 32.17% |
| March 22, 2024 | 23.08% |
| March 21, 2024 | 24.32% |
| March 20, 2024 | 30.58% |
| March 19, 2024 | 28.35% |
| March 18, 2024 | 28.35% |
| March 15, 2024 | 28.03% |
| March 14, 2024 | 25.77% |
| March 13, 2024 | 24.82% |
| March 12, 2024 | 24.28% |
| March 11, 2024 | 21.38% |
| March 08, 2024 | 14.48% |
| March 07, 2024 | 13.42% |
| March 06, 2024 | 15.96% |
| March 05, 2024 | 15.58% |
| March 04, 2024 | 16.77% |
| March 01, 2024 | 12.10% |
| February 29, 2024 | 8.72% |
| February 28, 2024 | 10.68% |
| February 27, 2024 | 3.91% |
| February 26, 2024 | 3.95% |
| February 23, 2024 | -5.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.32%
Minimum
Sep 11 2020
427.3%
Maximum
Jul 30 2019
-13.81%
Average
-41.53%
Median
Feb 08 2023
1 Year Total Returns (Daily) Benchmarks
| Aurinia Pharmaceuticals Inc | -56.37% |
| Edesa Biotech Inc | -40.91% |
| Lexaria Bioscience Corp | 93.21% |
| Xenon Pharmaceuticals Inc | 7.28% |
| ESSA Pharma Inc | 141.4% |